BioNexus Gene Lab Corp Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BioNexus Gene Lab Corp quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • BioNexus Gene Lab Corp Depreciation for the quarter ending March 31, 2024 was $20.1K, a 3.63% decline year-over-year.
  • BioNexus Gene Lab Corp annual Depreciation for 2023 was $83.3K, a 8.94% decline from 2022.
  • BioNexus Gene Lab Corp annual Depreciation for 2022 was $91.4K, a 0.16% increase from 2021.
  • BioNexus Gene Lab Corp annual Depreciation for 2021 was $91.3K, a 0.55% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $83.3K -$8.17K -8.94% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $91.4K +$145 +0.16% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $91.3K +$495 +0.55% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $90.8K +$49.1K +118% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-06
2019 $41.7K +$1.1K +2.72% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $40.6K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.